Evidence map›Paper›PMID 41866033›Full record

ArticleThe Journal of biological chemistry2026

Activation dynamics of a water-soluble human mu-opioid receptor.

Eugene Agyemang, Raegan Van Wirt, Calixte Walls, Thomas T Joseph, Sriram Tiruvadi-Krishnan, John Grothusen, Qiu Zhang, Alan Hicks, Wellington Leite, Naresh C Osti and 4 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eugene AgyemangUT-ORII Genome Science and Technology Graduate Program, University of Tennessee, Knoxville, Tennessee, USA.
Raegan Van WirtDepartment of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, Tennessee, USA.
Calixte WallsDepartment of Chemistry, University of Tennessee, Knoxville, Tennessee, USA.
Thomas T JosephDepartment of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Sriram Tiruvadi-KrishnanDepartment of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, Tennessee, USA.
John GrothusenDepartment of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Qiu ZhangNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Alan HicksNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Wellington LeiteNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Naresh C OstiNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Eugene MamontovNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Hugh M O'NeillNeutron Scattering Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Renyu LiuDepartment of Anesthesiology and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Electronic address: RenYu.Liu@pennmedicine.upenn.edu.
Rajan LamichhaneDepartment of Biochemistry & Cellular and Molecular Biology, University of Tennessee, Knoxville, Tennessee, USA. Electronic address: rajan@utk.edu.

Funding

Efficient prediction of transmembrane binding sites for anesthetic ligandsK08GM139031 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI JOSEPH, THOMAS THENGANPALLIL · 2020 to 2024
$984k
NIGMS NIH HHS K08 GM139031
6 · The paper itself

Abstract

The mu-opioid receptor (MOR), a class A G protein-coupled receptor mediates opioid analgesia and remains a central target for pain therapeutics. While crystal structures of MOR exist, they provide limited insight into the receptor's dynamic conformational landscape underlying function. Here, we engineered a thermostable water-soluble MOR variant (wsMOR) that retains native-like ligand-binding and activation dynamics. This variant enables high-yield production and detailed solution-phase structural studies that are challenging with membrane-embedded MOR, providing a valuable tool for studying receptor activation and aqueous-phase drug screening. Using a combined computational and experimental approach, we performed long-timescale all-atom molecular dynamics simulations together with neutron scattering and single-molecule FRET, revealing a structurally stable receptor with a diverse ensemble of conformations at different temporal resolutions. In the ligand-free state, wsMOR displayed high conformational flexibility, which decreased upon agonist binding, particularly in transmembrane helix 6, a hallmark of G protein-coupled receptor activation. Positive allosteric modulation and G protein binding further stabilized active-like states. These findings highlight wsMOR's conformational plasticity across picosecond to millisecond timescales and provide a foundation for structure-guided development of next-generation opioid ligands with improved efficacy and safety.

Indexed as

Molecular Dynamics SimulationReceptors, Opioid, muWaterFluorescence Resonance Energy TransferHumansLigandsSolubilityLigandsReceptors, Opioid, muWaterallosteric modulationg proteinG protein-coupled receptor (GPCR)mu-opioid receptorneutron scatteringsingle-molecule FRET (smFRET)structural dynamics

Identifiers

PMID41866033
PMCPMC13123355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.